Results 81 to 90 of about 7,701 (216)

Vitamin B6 metabolites in idiopathic calcium stone formers: no evidence for a link to hyperoxaluria [PDF]

open access: yes, 2018
Vitamin B6 metabolites and their potential correlates to urinary oxalate excretion in idiopathic calcium stone formers (ICSF) compared with healthy subjects were investigated.
Casez, Jean-Paul   +2 more
core  

Aldehyde Dehydrogenase 2 Gene Polymorphism and Alcohol Consumption Are Associated With Nephrolithiasis in a Chinese Population

open access: yesMolecular Genetics &Genomic Medicine, Volume 14, Issue 1, January 2026.
ALDH2 polymorphisms are associated with increased risk of nephrolithiasis in humans, and Aldh2 deficiency promotes kidney stone formation in mice, especially under alcohol exposure. ABSTRACT Background Nephrolithiasis is a common urological disorder and has become a significant global public health issue.
Tao Liu   +11 more
wiley   +1 more source

Probiotic Intervention in the Management of Urolithiasis: A Pathway to Gut Microbiome Modulation

open access: yesAdvanced Gut &Microbiome Research, Volume 2026, Issue 1, 2026.
Urolithiasis, or kidney stone disease, is a chronic, recurrent disorder that significantly impacts renal health. Despite the availability of pharmacological and dietary strategies, recurrence of urolithiasis remains a major challenge. Emerging research highlights the gut–kidney axis as a critical mediator in kidney stone pathophysiology, particularly ...
Roopa Shri Balakrishnan   +3 more
wiley   +1 more source

The Importance of Detecting the Signs of Primary Hyperoxaluria—Cardiac Oxalosis in Primary Hyperoxaluria Type 1

open access: yesAnnals of Internal Medicine: Clinical Cases
A 27-year-old man presented with influenza-like symptoms and rapidly progressing respiratory failure requiring mechanical ventilation and venovenous extracorporeal membrane oxygenation on the day of admission.
Salmina J. Guivala   +8 more
doaj   +1 more source

Metabolic alterations in non-alcoholic fatty liver disease (NAFLD): consequences of AGXT downregulation on glyoxylate detoxification [PDF]

open access: yes
Non-alcoholic fatty liver disease (NAFLD) encompasses a wide range of liver diseases, where excessive hepatic lipid accumulation is a common factor. It is highly prevalent worldwide, and is associated with an elevated risk of developing more severe liver
Gianmoena, Kathrin
core   +1 more source

Primary hiperoxaluria diagnosed after kidney transplantation: report of 2 cases and literature review

open access: yesBrazilian Journal of Nephrology
Primary hyperoxaluria (PH) is a very rare genetic disorder; it is characterized by total or partial deficiency of the enzymes related to the metabolism of glyoxylate, with an overproduction of calcium oxalate that is deposited in different organs, mainly
John Fredy Nieto Rios   +7 more
doaj   +1 more source

Effect of calcium intake on urinary oxalate excretion in calcium stone-forming patients [PDF]

open access: yes, 2002
Dietary calcium lowers the risk of nephrolithiasis due to a decreased absorption of dietary oxalate that is bound by intestinal calcium. The aim of the present study was to evaluate oxaluria in normocalciuric and hypercalciuric lithiasic patients under ...
Heilberg, Ita Pfeferman   +4 more
core   +3 more sources

Variability in urinary oxalate measurements between six international laboratories [PDF]

open access: yes, 2017
Background. Hyperoxaluria is a major risk factor for kidney stone formation. Although urinary oxalate measurement is part of all basic stone risk assessment, there is no standardized method for this measurement. Methods.
Adams Huet, Beverley   +12 more
core  

Systemic Oxalosis in Infants: Two Cases and Literature Review

open access: yesTurkish Journal of Nephrology, 2019
The infantile form of primary hyperoxaluria is a very rare disease and often presents as a lifethreatening condition because of rapid progression to end-stage renal disease and systemic oxalosis.
Zübeyde GÜNDÜZ   +5 more
doaj  

CRISPR/Cas9-mediated glycolate oxidase disruption is an efficacious and safe treatment for primary hyperoxaluria type I

open access: yesNature Communications, 2018
Substrate reduction therapies (SRT) are a promising therapeutic approach for monogenic inherited metabolic diseases. Here the authors evaluate the therapeutic potential of an in vivo CRISPR/Cas9-mediated SRT to treat primary hyperoxaluria type I and ...
Nerea Zabaleta   +16 more
doaj   +1 more source

Home - About - Disclaimer - Privacy